Sunday, February 5, 2023 | Back issues
Courthouse News Service Courthouse News Service


SAN FRANCISCO - Impax Laboratories must face claims from shareholders that it ignored warnings from the Food and Drug Administration about deficient manufacturing conditions, among other issues, a federal judge ruled.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.